Peptide LocalCompare price, evidence & access
Search /Compare vendors
Locations/United States/Orforglipron / Foundayo
Purchase and availability checkOrforglipron / Foundayo in the United States

Can you buy Orforglipron in the United States?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. FOUNDAYO received FDA approval on April 1, 2026 under NDA 220934 for a defined adult weight-management population.

Direct answers →Open official records →Open the interactive status check
Evidence lane
US FDA medicine approval
Destination
United States
Source records
3
Reviewed
July 21, 2026
ByPeptide Local Editorial DeskUpdated July 21, 2026How we review
Direct answers

What this exact search can and cannot establish.

Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.

01

Can you buy Orforglipron in the United States?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. FOUNDAYO received FDA approval on April 1, 2026 under NDA 220934 for a defined adult weight-management population. The approval belongs to the exact tablets, label, manufacturer, prescription product, and US supply record. It does not transfer to a powder, research listing, imported presentation, or online product using the orforglipron name. Before acting on an offer, match the exact product, authorization, seller identity, and supply route in the official records below.

02

Which official records should be checked for Orforglipron / Foundayo in United States?

Resolve the exact identity of Orforglipron / Foundayo through Current FOUNDAYO prescribing information from National Library of Medicine, DailyMed. Then search Drugs@FDA approved drug database from U.S. Food and Drug Administration for the destination product record and Locate a state-licensed online pharmacy from U.S. Food and Drug Administration for the seller, establishment, or supply route in United States. A match in one record does not replace the other two checks.

03

Does an online listing prove Orforglipron / Foundayo is authorized or available in United States?

No. A page using the name Orforglipron / Foundayo, local currency, a domestic delivery claim, or a familiar package image is only a lead. FOUNDAYO is an FDA-approved US oral medicine containing the non-peptide small molecule orforglipron. That US approval does not establish authorization, launch, prescription access, market presence, supply, or seller authority in another country, and it does not authenticate a same-name research or imported product. For United States, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.

Continue the exact comparison

Related country and compound records.

Compare another tracked name in United States, or keep Orforglipron / Foundayo fixed and change the destination within North America. The identity, product, and seller checks remain separate.

Continue the exact comparison

Orforglipron / Foundayo in North America

Orforglipron / Foundayo across 42 countries
Identity before availability

A name alone cannot establish a local verdict.

FOUNDAYO received FDA approval on April 1, 2026 under NDA 220934 for a defined adult weight-management population. The approval belongs to the exact tablets, label, manufacturer, prescription product, and US supply record. It does not transfer to a powder, research listing, imported presentation, or online product using the orforglipron name.

Primary identity source: Current FOUNDAYO prescribing information / National Library of Medicine, DailyMed ↗
Three-record verification path

Identity. Product. Seller or supply.

A credible result must keep these separate. The official links answer different questions and should be checked in sequence.

Current FOUNDAYO prescribing information

Current FOUNDAYO prescribing information is maintained by National Library of Medicine, DailyMed. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Current FOUNDAYO prescribing information ↗

Drugs@FDA approved drug database

Drugs@FDA approved drug database is maintained by U.S. Food and Drug Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Drugs@FDA approved drug database ↗

Locate a state-licensed online pharmacy

Locate a state-licensed online pharmacy is maintained by U.S. Food and Drug Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Locate a state-licensed online pharmacy ↗
United States / Country guide

United States market context.

A US peptide search can surface prescription drugs, compounded preparations, telehealth offers, and laboratory-research materials in one result set. Federal and state records answer different questions, so no single lookup validates every route.

  • FDA’s BeSafeRx directory sends consumers to each state board’s pharmacy-license database and says an unlisted online pharmacy should not be used.
  • Sections 503A and 503B apply different conditions to compounding from bulk drug substances; FDA updates the underlying lists and policies as substances are evaluated.
  • FDA’s peptide-related bulk-substance page identifies limited information or potential safety concerns for several names that also appear in research and wellness marketing.
Destination checklist

Repeat the country checks before comparing any offer.

The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.

01

Start with the seller class

For an online pharmacy claim, use FDA’s state-license directory to reach the relevant board database and match the business, address, and current license before comparing price.

02

Separate the federal record

Check FDA approval, shortage, outsourcing-facility, and bulk-substance records separately; a state pharmacy license does not make every product or compounding claim federally supported.

03

Keep research outside care

A laboratory-research listing is not a prescription pathway. Compare only like-for-like catalog rows and retain the research-only boundary, source date, shipping claim, and evidence-access label.

Primary evidence

Audit every source used by this page.

Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.

01
Current FOUNDAYO prescribing informationNational Library of Medicine, DailyMed
02
Drugs@FDA approved drug databaseU.S. Food and Drug Administration
03
Locate a state-licensed online pharmacyU.S. Food and Drug Administration
04
FDA approves FoundayoU.S. Food and Drug Administration
05
Bulk drug substances used in compoundingU.S. Food and Drug Administration
06
Peptide and other bulk-substance safety risksU.S. Food and Drug Administration
Audit and handoff

Keep the exact record attached.